Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents
2019
Background
Sofosbuvir is the keystone of direct antiviral agents for the chronic hepatitis C (CHC). The safety of sofosbuvir in patients with stage 4–5 chronic kidney disease (CKD) needs further observation in real world.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
8
References
1
Citations
NaN
KQI